Phase I Immunotherapy Study of Nivolumab mono therapy and in combination with ipillmumab

May 13th, 2016|

Principal Institution: Memorial Sloan Kettering Cancer Center – This Phase 1 clinical trial tests the safety and efficacy of combination checkpoint inhibitors in the treatment of children with brain […]